The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload

British Journal of Haematology

Volumn 94, Issue 2, 1996, Pages 288-299

  Jensen, P D ^a   Heickendorff, L ^a   Pedersen, Bent ^a   Bendix Hansen, K ^a   Jensen, F T ^a   Christensen, T ^a   Boesen, A M ^a   Ellegaard, J ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

desferrioxamine; iron overload; myelodysplastic syndromes; transferrin receptor

Indexed keywords

DEFEROXAMINE; HEMOGLOBIN; IRON; ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOPENIA; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMATOPOIESIS; HUMAN; IRON CHELATION; IRON OVERLOAD; MALE; MYELODYSPLASTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; CHELATION THERAPY; DRUG DOSE INCREASE; HUMAN CELL; MIDDLE AGED; NEUTROPHIL COUNT; THROMBOCYTE COUNT; YOUNG ADULT;

EID: 0029933087     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1795.x     Document Type: Article

References (28)

1. Beguin, Y., Clernoris, G.K., Pootrakul, P. & Fillet, G. (1993) Quantitative assessment of erythropoiesis and functional classification of anaemia based on measurements of serum transferrin receptor and erythropoietin. Blood, 81, 1067-1076.
2. Beguin, Y., Huebers, H.A., Josephson, B. & Finch, C.A. (1988) Transferrin receptors in rat plasma. Proceedings of the National Academy of Sciences of the United States of America, 85, 637-640.
3. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
4. Bowen, D.T., Culligan, D., Beguin, Y., Kendall, R. & Willis, N. (1994) Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters. Leukemia, 8, 151-155.
5. Cazzola, M., Barosi, G., Gobbi, P.G., Invernizzi, R., Riccardi, A, & Ascari, E. (1988) Natural history of idiopathic refractory sideroblastic anemia. Blood, 71, 305-312.
6. Cazzola, M., Ponchio, L., Beguin, Y., Rosti, V., Bergamashi, G., Liberato, N.L., Fregoni, V., Nalli, G., Barosi, G. & Ascari, E. (1992) Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders: result of a phase I/II clinical trial. Blood, 79, 29-37.
7. Chitambar, C.R., Loebel, A.M. & Noble. N.A. (1991) Shedding of transferrin receptor from rat reticulocytes during maturation in vitro: soluble transferrin receptor is derived from receptor shed in vesicles. Blood, 78, 2444-2450.
8. Chui, D.H.K. & Clarke, B.J. (1982) Abnormal erythroid progenitor cells in human preleukemia. Blood, 60, 362-367.
9. Dezza, L., Cazzola, M., Danova, M., Carlo-Stella, C., Bergamaschi, G., Brugnatelli, S., Invernizzi, R., Mazzini, G., Riccardi, A. & Ascari, E. (1989) Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies, Leukemia, 3, 104-107.
10. Kstrov, Z., Tawa, A., Wang, X., Dubé, I.D., Suhl, H., Cohen, A., Gelfand, E.W. & Freedman, M.H. (1987) In vitro and in vivo effects of desforoxamine in neonatal acute leukemia. Blood, 69, 757-761.
11. Ganong, W.F. (1979) Review of Medical Physiology, 8th edn, pp. 10-11. Lange Medical Publications, Los Altos, California.
12. Ghio, R., Ballerari, E., Ballestrero, A., Gatti, A.M., Mareni, C., Massa. G., Patrone, F., Sessarego, M. & Timitilli, S. (1993) Subcutaneous recombinant human erythropoietin for the treatment of anaemia in myelodysplastic syndromes. Acta Haematologica, 90, 58-64.
13. Hoffbrand, A.V. & Wonke, B. (1989) Results of long-term subcutaneous desferrioxamine therapy. Bailliere's Clinical Haematology, 2, 345-362.
14. Huebers, H.A., Beguin, Y., Pootrakul, P., Einspahr, D. & Finch, C.A. (1990) Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood, 75, 102-107.
15. Jensen, I.M., Hokland, M. & Hokland, P. (1993) A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry. Leukemia Research, 17, 839-846.
16. Jensen, P.D., Jensen, F.T., Christensen, T. & Ellegaard, J. (1994) Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. British Journal of Haematology. 87, 171-184.
17. Jensen, P.D., Jensen, I.M. & Ellegaard, J. (1992) Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome. British Journal of Haematology, 80, 121-124.
18. Johnston, D.L., Rice, L., Vick, G.W., Hedrick, T.D. & Rokey, R. (1989) Assessment of tissue iron overload by nuclear magnetic resonance imaging. American Journal of Medicine, 87, 40-47.
19. Koch, J., Hindkjaer, J., Kolvraa, S. & Bolund, S. (1995) Construction of a panel of chromosome specific oligonucleotide probes (PRINS-primers) useful for the identification of individual human chromosomes in situ. Cytogenetics and Cell Genetics, 71, 142-147.
20. Lintula, R. (1986) Ferrokinetic abnormalities and red cell life span in myelodysplastic syndromes: a review. Scandinavian Journal of Haematology, 36, 48-52.
21. Pedersen, B. & Kerndrup. G. (1986) Specific minor chromosome deletions consistently occurring in myelodysplastic syndromes. Cancer Genetics and Cytogenetics, 23, 61-75.
22. Pippard, M.J. (1989) Desferrioxamine-induced iron excretion in humans. Bailliere's Clinical Haematology, 2, 323-343.
23. Porfirio, B., Ambroso, G., Giannella, G., Isacchi, G. & Dallapiccola, B. (1989) Partial correction of chromosome instability in Fanconi anemia by desferrioxamine. Human Genetics, 83, 49-51.
24. 59Fe. British Journal of Haematology, 31, 65-75.
25. Schafer, A., Cheron, R.G., Dluhy, R., Cooper, B., Gleason, R.E., Soeldner, J.S. & Bunn, H.F. (1981) Clinical consequences of acquired transfusional iron overload in adults. New England Journal of Medicine, 304, 319-324.
26. Shih, Y.J., Baynes, R.D., Hudson, B.G. & Cook, J.D. (1993) Characterization and quantitation of the circulating forms of serum transferrin receptor using domain-specific antibodies. Blood, 81, 234-238.
27. Wang, G.L. & Semenza, G.L. (1993) Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood, 82, 3610-3615.
28. Yunis, J.J. (1981) New chromosome techniques in the study of human neoplasia. Human Pathology, 12, 540-549.